Patient-Derived Xenograft Models: A New Era in Preclinical Oncology
Patient Derived Xenograft (PDX) Model Market Overview
The Patient Derived Xenograft (PDX) model market has become a cornerstone of preclinical oncology research and drug development. This model involves implanting human tumor tissues into immunodeficient mice, enabling researchers to analyze cancer behavior and test therapies in a living organism that mirrors the original...
0 Comments
0 Shares